Top Suppliers:I want be here

63610-08-2

63610-08-2 structure
63610-08-2 structure
  • Name: Indobufen
  • Chemical Name: 2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid
  • CAS Number: 63610-08-2
  • Molecular Formula: C18H17NO3
  • Molecular Weight: 295.33
  • Catalog: API Blood system medication Anticoagulant and antiplatelet drugs
  • Create Date: 2018-08-09 11:34:32
  • Modify Date: 2024-01-02 11:41:31
  • Indobufen is a platelet aggregation inhibitor. Indobufen is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes[1].

Name 2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid
Synonyms 4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-benzeneacetic acid
Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-, (±)-
(±)-4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-a-ethylbenzeneacetic Acid
2-[4-(1-Oxo-1,3-dihydro-isoindol-2
MFCD00572250
2-[4-(1-Oxo-1,3-dihydro-2H-isoindol-2-yl)phenyl]butanoic acid
Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-
K-3920
UNII-6T9949G4LZ
1-Oxo-2-[p-[(a-ethyl)carboxymethyl]phenyl]isoindoline
EINECS 264-364-4
2-(4-(1-Oxo-2-isoindolinyl)phenyl)butyric acid
Ibustrin
1-Oxo-2-(p-((α-ethyl)carboxymethyl)phenyl)isoindoline
2-[4-(1-Carboxypropyl)phenyl]-1-isoindolinone
(±)-2-[p-(1-Oxo-2-isoindolinyl)phenyl]butyric Acid
Butyric acid, 2-(p-(1-oxo-2-isoindolinyl)phenyl)-, (±)-
Indobufen
2-[4-(1-oxo-1,3-dihydro-isoindol-2-yl)-phenyl]-butyric acid
2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoic acid
Indobufen (INN)
(±)-2-(p-(1-Oxo-2-isoindolinyl)phenyl)butyric acid
Description Indobufen is a platelet aggregation inhibitor. Indobufen is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes[1].
Related Catalog
Target

COX

In Vitro Indobufen does not affect both Cox-1 and Cox-2 protein, whereas Indobufen reduces TxB2 levels. Indobufen inhibits TxA2 but not PGE2 synthesis in LPS-stimulated monocytes. Indobufen reduces the extent of ERK1/2 phosphorylation, whereas the levels of phosphorylated p38 are unaltered[1].
References

[1]. Eligini S, et al. Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. Cardiovasc Res. 2006 Jan;69(1):218-26.

Density 1.3±0.1 g/cm3
Boiling Point 518.1±50.0 °C at 760 mmHg
Melting Point 33-34 °C(lit.)
Molecular Formula C18H17NO3
Molecular Weight 295.33
Flash Point 267.1±30.1 °C
Exact Mass 295.120850
PSA 57.61000
LogP 3.30
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.630

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ET5955800
CHEMICAL NAME :
Butyric acid, 2-(p-(1-oxo-2-isoindolinyl)phenyl)-, (+-)-
CAS REGISTRY NUMBER :
63610-08-2
LAST UPDATED :
199710
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C18-H17-N-O3
MOLECULAR WEIGHT :
295.36
WISWESSER LINE NOTATION :
T56 BVN DHJ CR DY2&VQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
373 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
345 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
333 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
697 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
365 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
370 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
WGK Germany 3
HS Code 2942000000
HS Code 2918300090
Summary 2918300090 other carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%